Tennessee Pharmacists Association
You Have a Voice: TPA

The 2015 Legislative Session has ended, and it’s safe to say that TPA members, leaders, and staff have been very busy this session! This year, TPA tracked nearly 100 pieces of legislation at the State level and engaged on many bills. Here are some of the most important pharmacy-related legislative initiatives TPA engaged in during the 2015 session.

TOP 5 TPA LEGISLATIVE PRIORITIES IN 2015

RESTORATION OF PROPOSED AWP-BASED CUTS TO THE TENNCARE PHARMACY PROGRAM

TPA successfully worked with members of the Tennessee General Assembly, in collaboration with several other pharmacy-related organizations, to restore funding for the proposed AWP cuts to the TennCare pharmacy program. These proposed TennCare AWP cuts would have reduced AWP-based reimbursements to pharmacies by over $17.4 million (total state and federal funding) for brand, generic, and specialty medications. The legislature did not allocate funding to restore the proposed cuts to buprenorphine and compounding for the TennCare program, and these cuts will go into effect on July 1, 2015. The budget, as adopted by the House and the Senate, earmarked funds to restore these AWP-based cuts to pharmacy, effectively removing them from consideration in this upcoming Fiscal Year 2016 budget. If implemented, these AWP-based cuts would have affected all pharmacy providers that currently accept TennCare patients, so this is a win for our patients and the entire profession of pharmacy. This victory was due in large part to the dedicated efforts of pharmacists and pharmacy professionals who contacted legislators about these cuts. Thank you all for your hard work!

Testimonies by bill sponsors and pharmacists regarding TennCare budget cuts:

  • Senate Health: CLICK HERE (start at 1:22:00 mark)
  • House Health: CLICK HERE (start at 1:10:00 mark)
  • Opinion editorial submitted by TPA President Jim McBride to the Tennessean regarding these cuts: CLICK HERE

TPA thanks state legislators, and especially Chairman Randy McNally, Chairman Rusty Crowe, Representative Ferrell Haile, Representative David Shepard, and Chairman Cameron Sexton, for their hard work on this issue. TPA also encourages members to contact your legislators to thank them for their efforts in restoring these AWP-based budget cuts.

DIABETES SALES TAX

After many years of working on this legislation, TPA was successful in working with Senator Doug Overbey and Representative David Shepard to enact Public Chapter 274 in 2015. As a reminder, under the Durable Medical Equipment Act [TCA 67-6-102 (34)(A)], glucometers used for diabetic testing are defined as durable medical equipment and are exempt from sales tax pursuant to a prescription order [TCA 67-6-314(2)].  However, the lancets and strips that are essential to utilize these glucometers have not been exempted.  While nearly all health insurance companies pay for these supplies, the pharmacy reimbursement has not included sales tax. This legislation amends Section 67-6-314(7) to exempt the sale of diabetic testing supplies from state and local tax, including any syringe used to dispense insulin for human use and diabetic testing supplies for human use, including lancets, test strips for blood glucose monitors, visual read test strips, and urine test strips. This legislation had a $2.4 million fiscal note this year.

  • Legislation: Public Chapter 274 (HB 0122 by Shepard, Fitzhugh  / SB 0033 Overbey, Haile, Tate, Crowe)
  • Result: Passed
  • Summary Statement: As enacted, exempts diabetic testing supplies from sales and use tax.
  • Effective Date: July 1, 2015
  • TPA Summary of Legislation

TPA thanks state legislators, and especially Senator Doug Overbey and Representative David Shepard, for their hard work in passing this legislation and gaining funding to enact this legislation.

PHARMACY DRUG DISPOSAL

TPA was successful in working with Representative David Shepard and Senator Doug Overbey to enact Public Chapter 40, the “Ensuring Patient Access to Pharmacy Drug Disposal Programs Act of 2015”. This legislation obtained unanimous support from state legislators and the Governor’s office. This legislation has three primary points: 1) pharmacist participation in drug disposal programs shall be voluntary, 2) the pharmacist in charge shall be responsible for deciding whether the pharmacy participates in a pharmacy drug disposal program, and 3) the pharmacy practice site shall be held harmless and shall not be held liable for any theft, robbery, or other criminal activity related to its participation in the pharmacy drug disposal program, as long as the site is acting in good faith and operating in compliance with all state and federal rules and regulations regarding drug disposal.

  • Legislation: Public Chapter 40 (HB 0229 by Shepard, Windle, Love, Pitts, Terry, Shaw, Clemmons, Howell, Favors, Sexton C, Lamberth, Hardaway / SB 0409 by Overbey, McNally, Yarbro)
  • Result: Passed
  • Summary Statement: As enacted, enacts the “Ensuring Patient Access to Pharmacy Drug Disposal Programs Act of 2015”.
  • Effective Date: July 1, 2015
  • TPA Summary of Legislation

TPA thanks state legislators, and especially Senator Doug Overbey and Representative David Shepard, for their hard work to pass this legislation.

PHARMACY ROBBERY LEGISLATION

Tennessee currently ranks 4th per capita in the United States in pharmacy robberies, and 5th in number of pharmacy robberies. This session, TPA worked with Senator Ferrell Haile and Representative David Shepard to introduce legislation which would allow courts to apply enhancing factors if the individual commits robbery, aggravated robbery, or especially aggravated robbery involving controlled substances on the premises of a licensed pharmacy. Because this legislation is expected to increase costs to the state of Tennessee for enhancing penalties and extending the length of incarceration for these criminals, this legislation received a substantial fiscal note. This legislation was passed by the House Criminal Justice Subcommittee and Criminal Justice Committee, as well as the Senate Judiciary Committee, but did not receive funding necessary to enact it during the 2015 legislative session. Although not enacted, this legislation did provide TPA with a very important opportunity to educate legislators and the public about the dangers facing our patients, pharmacists, and pharmacy professionals every single day with respect to the rising trend in pharmacy robberies occurring in Tennessee and across the nation. TPA will work with members of the Tennessee General Assembly to seek funding to support this legislation during the 2016 session.

Sentencing Enhancement Factor

  • Legislation: HB 0587 by Shepard / SB 0593 by Haile
  • Result: Considered but not passed
  • Summary Statement: As introduced, creates a new sentencing enhancement factor when the defendant committed the offense of robbery, aggravated robbery, or especially aggravated robbery on the premises of a licensed pharmacy.
  • Senate: Passed by Senate Judiciary Committee; Deferred to 2016 in Senate Finance, Ways, and Means
  • House: Passed by House Criminal Justice Subcommittee and Committee; Deferred to 2016 in House Finance, Ways, and Means
  • TPA Summary of Legislation

Mandatory Minimum Sentences and Fine Increases

  • Legislation: HB 0230 by Shepard / SB 0437 by Haile
  • Result: Considered but not passed
  • Summary Statement: As introduced, requires a person who commits robbery within or on the premises of a licensed pharmacy for the purpose of obtaining, selling, delivering, giving, or exchanging a controlled substance to serve at least the minimum sentence for the offender’s appropriate range of sentence and be subject to increased fines.
  • TPA Summary of Legislation

Testimonies by bill sponsors, pharmacists, and student pharmacists regarding pharmacy robberies:

  • Senate Judiciary (part 1): CLICK HERE (start at 2:08:00 mark)
  • Senate Judiciary (part 2): CLICK HERE (start at 1:15:00 mark)
  • House Criminal Justice: CLICK HERE (starts at 52:29 mark)

TPA thanks state legislators, and especially Senator Ferrell Haile and Representative David Shepard, for their hard work and efforts regarding this legislation.

MEDICATION THERAPY MANAGEMENT IN MEDICAID

TPA worked with Chairman Randy McNally to support Senate Joint Resolution 104, a resolution which urges the Bureau of TennCare to incorporate Medication Therapy Management to benefit patients, improve quality, and control costs. This was a very positive resolution and TPA was heavily engaged in supporting this effort. According to information provided by the Bureau of TennCare in conjunction with this resolution, the underlying purpose of Medication Therapy Management is to improve quality and cost effectiveness, and the TennCare pharmacy team has been evaluating MTM as a potential cost savings measure which may be implemented with or without the resolution. The Bureau of TennCare also noted that if medication management therapy was mandated, it could be implemented in a manner that was at worst revenue neutral.

  • Legislation: Senate Joint Resolution 104 by Chairman McNally
  • Result: Passed by Senate
  • Summary Statement: This resolution urges the bureau of TennCare to incorporate medication therapy management into all of its healthcare delivery systems so as to improve patient outcomes and control costs.
  • Testimony on SJR 104

TPA thanks state legislators, and especially Chairman Randy McNally, for his hard work and efforts regarding this resolution.


PHARMACY-RELATED LEGISLATION ENACTED IN 2015

DEXTROMETHORPHAN REGULATIONS

Statistics from the NSDUH show that abuse of dextromethorphan is at its highest prevalence among 12-to-17-year-olds. In order to combat the abuse of dextromethorphan for this population, this law prohibits the sale of products containing dextromethorphan to anyone less than 18 years of age. TPA worked with the sponsors of this legislation to ensure that pharmacists can continue to provide care to all patients. TPA worked with legislators to exclude pharmacist-generated prescriptions, ensure that all retailers that sell dextromethorphan, including non-pharmacies, are required to comply with this law, move the implementation date back from July 1, 2015, to January 1, 2016, exempt hospitals and other institutional facilities, and reduce the penalty from a misdemeanor to a civil penalty.

  • Legislation: Public Chapter 82 (HB 0039 by Lamberth, Ragan, Powers, Keisling, Williams, Casada, Sexton C, Travis, Sargent, Shepard, Terry, Sexton J / SB 0045 by Haile)
  • Result: Passed
  • Summary Statement: As enacted, prohibits the retail sale of products containing dextromethorphan to persons who are less than 18 years of age; prohibits the purchase of products containing dextromethorphan by persons who are less than 18 years of age.
  • Effective Date: January 1, 2016

INTERCHANGE OF BIOLOGICALS

This legislation was brought by a coalition consisting of brand and generic biological drug manufacturers. This bill authorizes a pharmacist to substitute an interchangeable biological product for a prescribed biological product if certain requirements are met. TPA was very supportive of the intent of this legislation but did express concerns with the language as originally introduced. TPA was able to successfully work with bill sponsors to incorporate several key changes into this legislation. TPA worked to exempt vaccines, incorporate collaborative pharmacy practice agreement language as one accepted method of communication back to the prescriber, remove requirements for notification if the pharmacist dispenses a “new” prescription which has not been changed from the previously dispensed prescription, incorporate a sunset provision for notification requirements if the state mandates electronic medical records, and require notification only after dispensing (within 5 business days). TPA appreciates the efforts of the bill sponsors in working with TPA to make these important changes to ease the notification requirements. However, the impact of this legislation is not yet known due to the fact that there are no interchangeable biological products currently on the market.

  • Legislation: Public Chapter 371 (HB 0572 by Sexton, Hazelwood / SB 0984 by Norris)
  • Result: Passed
  • Summary Statement: As enacted, defines a “biological product” and an “interchangeable biological product” in the Tennessee Affordable Drug Act of 2005; authorizes a pharmacist to substitute an interchangeable biological product for a prescribed biological product if certain requirements are met.
  • Effective Date: May 4, 2015

ELECTRONIC RECORDS IN PUBLIC HEALTH THREATS

In response to recent outbreaks that have threatened the health of those around the country, legislation was brought by the Department of Health to gain quick access to medical records for patients. Access to these records shall be given in the most efficient and expedient means possible in order to facilitate investigations and inquiries while responding to an immediate threat to public health. Electronic access shall be limited to the minimum necessary for the duration of the outbreak, event, or time in which the public health is under immediate threat as determined by the commissioner.

  • Legislation: Public Chapter 154 (HB 0087 by McCormick, Brooks K, Ramsey, Hardaway / SB 0098 by Norris, Hensley)
  • Result: Passed
  • Summary Statement: As enacted, upon request by the commissioner of health or commissioner’s designee, requires that commissioner or designee be given certain access to medical records in order to facilitate investigations and inquiries when responding to an immediate threat to public health.
  • Effective Date: April 16, 2015

CONTROLLED SUBSTANCE SCHEDULING

This legislation updates the schedule of some controlled substances, such as hydrocodone containing products, as well as adding some new illicit substances to the list of schedule I substances that have been discovered in the past year. Please see Public Chapter 302 for a full list of controlled substances with their corresponding schedule.

  • Legislation: Public Chapter 302 (HB 0287 by McCormick, Brooks K, Powers / SB 0318 by Norris, McNally, Bowling, Briggs)
  • Result: Passed
  • Summary Statement: As enacted, revises various provisions of law regarding the scheduling of controlled substances and their analogues and derivatives, including updated identifications of drugs categorized in Schedules I-V.
  • Effective Date: July 1, 2015

LOW-THC CANNABIDIOL OIL

This law decriminalizes patients or their caregivers who possess oil that contains the substance cannabidiol, with less than nine-tenths of one percent (0.9%) of tetrahydrocannabinol (THC). The oil must be labeled by the manufacturer that it contains less than the limit of THC. The patient also must be in possession of proof that they were allowed to purchase the oil, such as a registration card, from the state where the oil was obtained. The patient also must have documentation of intractable seizures or epilepsy by a medical doctor or doctor of osteopathic medicine who is licensed to practice medicine in the state of Tennessee.

  • Legislation: Public Chapter 352 (HB 0197 by Faison, Jernigan, Parkinson, Carter, Hawk, Jones, Daniel, Goins, Sexton J, White M, Akbari, Miller, Hulsey, Clemmons, Favors, Durham, Gravitt, Kane, Hardaway / SB 0280 by Massey, Niceley, Kyle, Bowling, Gardenhire, Tate, Yarbro)
  • Result: Passed
  • Summary Statement: As enacted, authorizes use of cannabidiol oil with less than 0.9 percent of tetrahydrocannabinol to treat intractable seizures or epilepsy in certain circumstances.
  • Effective Date: May 4, 2015

PSEUDOEPHEDRINE LEGISLATION

This legislation provides clarifying language regarding the formula for calculating daily, monthly, and yearly limits on the weight of pseudoephedrine products sold.

  • Legislation: Public Chapter 59 (HB 0100 by McCormick, Brooks K, Powers, Windle / SB 0111 by Norris, Haile, Bowling)
  • Result: Passed
  • Summary Statement: As enacted, changes the limit calculations for immediate methamphetamine precursors from the total amount of the base ephedrine and pseudoephedrine in a product to the amount of ephedrine or pseudoephedrine base, or their salts, isomers, or salts of isomers contained in a product.
  • Effective Date: April 22, 2015

ADDICTION TREATMENT ACT

The Addiction Treatment Act was brought by the Tennessee Medical Association to provide protection and help for those who are suffering from the disease of addiction. As enacted, this legislation provides Good Samaritan protections for an individual who is having a drug overdose or in good faith seeks medical assistance for a person experiencing or believed to be experiencing a drug overdose. It also limits the prescribing of buprenorphine/naloxone to a healthcare provider with a DEA X license and only in circumstances in which the FDA has approved the use of the drug. This law also repeals a section of the code that allows an insurer to prohibit payment to a provider if the patient seeks treatment and it is determined that the patient is under the influence of alcohol or illegal drugs.

  • Legislation: Public Chapter 396 (HB 1036 by Dunn, Haynes, Ramsey, Powell, Hardaway / SB 0871 by Dickerson, Yager)
  • Result: Passed
  • Summary Statement: As introduced, enacts the “Addiction Treatment Act of 2015.”
  • Effective Date: July 1, 2015

PAIN MANAGEMENT CLINIC REQUIREMENTS

As prescription drug abuse continues to affect many Tennesseans, legislators have been trying to tackle the issue from every angle. This year, one of the approaches was to revise the requirements for medical directors and those participating in the operation of pain management clinics. Before this legislation was passed, any licensed physician could be the medical director of a pain management clinic. This legislation requires that medical directors of pain management clinics hold a specialty license in pain management.

  • Legislation: Public Chapter 475 (HB 1157 by Ramsey, Doss, Stewart, Dunn, Smith, Ragan, Lundberg, Hazlewood, Todd, Travis, Sargent, Powers, Brooks H, Johnson, Weaver, Howell, Lynn / SB 1266 by Yager, Briggs, Crowe, Massey, McNally, Bowling)
  • Result: Passed
  • Summary Statement: As enacted, revises requirements for medical directors and others participating in the operation of a pain management clinic.
  • Effective Date: July 1, 2015

CONTROLLED SUBSTANCE PRESCRIBING

Under present law, the top 50 prescribers of controlled substances are required, at the discretion of the department of health, to submit to the department within 15 business days, through registered or electronic mail, an explanation justifying the amounts of controlled substances prescribed in the relevant period of time. This legislation adds to this provision the top 10 prescribers of controlled substances in all of the counties combined having a population of less than 50,000 according to the 2010 census.

  • Legislation: Public Chapter 476 (HB 1216 by Doss, Lamberth, Farmer / SB 1287 by Hensley)
  • Result: Passed
  • Summary Statement: As enacted, adds the provision to the top 10 prescribers of controlled substances in all of the counties combined having a population of less than 50,0000 to provide an explanation to the department of health justifying the amount of controlled substances they prescribed.
  • Effective Date: May 18, 2015

RIGHT TO TRY ACT

The “Tennessee Right to Try Act” would allow Tennessee prescribers to prescribe drugs that have already undergone phase 1 U.S. Food and Drug Administration clinical trials. People with an advanced illness, which is considered as a ‘progressive disease or medical or surgical condition that entails significant functional impairment, that is not considered by a treating physician to be reversible even with administration of current federal drug administration approved and available treatments, and that, without life-sustaining procedures, will soon result in death’, would be allowed to take these medications. These medications would come directly from the manufacturer to the patient.

  • Legislation: Public Chapter 376 (HB 0143 by Lundberg, Goins, Butt, Weaver, McManus, Terry, Daniel, Rogers, Holt, Carter, Lynn, Kumar, Jernigan, Shepard, Powell, Hardaway, Byrd, Eldridge, Powers, Coley, Turner, Armstrong, Hazlewood / SB 0811 by Hensley, Haile, Stevens)
  • Result: Passed
  • Summary Statement: As enacted, enacts the “Tennessee Right to Try Act.”
  • Effective Date: July 1, 2015

BOARD OF PHARMACY LICENSURE

  • Legislation: Public Chapter 293 (HB 0086 by McCormick, Brooks K, Williams / SB 0097 by Norris, McNally)
  • Result: Passed
  • Summary Statement: As enacted, clarifies and adds to present law licensure requirements for persons who provide warehousing or third-party logistics services with regard to controlled substances.
  • Effective Date: April 24, 2015

PRESCRIBING BY NURSE ANESTHETISTS

  • Legislation: Public Chapter not available yet (HB 0629 by Littleton / SB 1014 by Dickerson, Green)
  • Result: Passed
  • Summary Statement: As enacted, revises definitions of prescription order and professional nursing in pharmacy and nursing statutes to include certain orders and activities of certified registered nurse anesthetists.
  • Effective Date: May 20, 2015

INTRACTABLE PAIN ACT

  • Legislation: Public Chapter 26 (HB 0031 by Williams, Kumar, Keisling, Dunn, Lundberg, Doss, Powers, Butt, Ragan, Rogers, Carr , Carter, Holsclaw, Terry, White M, Reedy, Byrd, Brooks H, Haynes, Smith / SB 0157 by Bowling, McNally, Yager, Watson, Jackson, Bailey, Haile, Kyle)
  • Result: Passed
  • Summary Statement: As enacted, deletes the Intractable Pain Act.
  • Effective Date: July 1, 2015

DEPARTMENT OF HEALTH

  • Legislation: Public Chapter 18 (HB 0366 by Faison, Ragan / SB 0233 by Bell)
  • Result: Passed
  • Summary Statement: As enacted, extends the department of health, June 30, 2019, and requires the department to report back to the committee concerning the findings in its 2014 performance audit report.
  • Effective Date: March 27, 2015

ABUSE OF VULNERABLE INDIVIDUALS

  • Legislation: Public Chapter 94 (HB 0088 by McCormick, Brooks K, Rogers, Littleton, Kane / SB 0999 by Norris, Crowe)
  • Result: Passed
  • Summary Statement: As enacted, adds defined terms and rulemaking authority concerning the registry of persons who have abused, neglected, or misappropriated the property of vulnerable individuals; increases from 30 days to 60 days the time within which placement on the registry may be appealed based on administrative error.
  • Effective Date: July 1, 2015

TELEHEALTH

  • Legislation: Public Chapter 261 (HB 0699 by Sexton C, Terry, Ragan, Carr, Gravitt, Weaver, Moody, Littleton, Carter, Powers, Byrd, Reedy, Forgety, Keisling, Hazlewood, Wilburn, Lamberth, Daniel, Rogers, Ramsey, Camper, Hardaway, Fitzhugh, Butt, Powell, Kane, Parkinson, McManus, Akbari / SB 1223 by Bell, Green, Overbey, Gardenhire, Haile, Stevens, Yager)
  • Result: Passed
  • Summary Statement: As enacted, establishes requirements and protections for healthcare providers that practice telehealth.
  • Effective Date: July 1, 2015

MEDICAL MALPRACTICE

  • Legislation: Public Chapter 268 (HB 1003 by Lundberg / SB 0892 by Kelsey)
  • Result: Passed
  • Summary Statement: As enacted, provides that a healthcare provider’s disclosure of relevant information in response to a court order, including, but not limited to, protected health information, opinions as to the standard of care of any defendant, compliance with or breach of the standard, and causation of the alleged injury, will be deemed a permissible disclosure.
  • Effective Date: April 24, 2015

PHYSICIAN ASSISTANT REGULATIONS

  • Legislation: Public Chapter 189 (HB 1101 by Hill T / SB 0201 by Crowe, Yarbro)
  • Result: Passed
  • Summary Statement: As enacted, deletes statement that a physician assistant’s supervising physician have complete and absolute authority over the physician assistant’s actions while retaining language that the physician assistant function under the control and responsibility of the physician.
  • Effective Date: July 1, 2015

PHARMACY-RELATED LEGISLATION CONSIDERED BUT NOT ENACTED IN 2015

MEDICATION SYNCHRONIZATION

This bill was brought by the American Cancer Society, and seeks to require that a contract or policy of an insurer that provides benefits for prescription drugs must include certain provisions to allow for medication synchronization. These provisions would apply to all insurers that are not preempted by federal law, including TennCare. TPA continues to support and advocate for the role of the pharmacist in improving medication adherence for patients, including the incorporation of medication synchronization programs into daily practice. However, due to the mandates and requirements placed on insurers, including TennCare, this bill received a significant fiscal note from the state of Tennessee, and action on this legislation has been deferred to 2016.

  • Legislation: HB 0475 by Shepard, Clemmons, Shaw, Terry, Jernigan, Williams, Durham / SB 0497 by Haile, Dickerson, McNally, Harris, Massey
  • Result: Considered but not passed
  • Summary Statement: As introduced, authorizes the synchronization of a patient’s medications and regulates patient cost-sharing and pharmacist dispensing fees affected by a synchronization.
  • No action taken in 2015.

TENNCARE PHARMACY POSTING

Under present law, all managed care organizations, contractors, subcontractors, providers, or any other person or entity must advise the office of the TennCare inspector general immediately when there is actual knowledge, not subject to a testimonial privilege, that an act of recipient, enrollee, or applicant fraud is being, or has been committed. This bill requires any pharmacy contracting with TennCare to post and maintain, in a conspicuous place that is frequently seen by pharmacists and pharmacy technicians, a printed notice regarding reporting TennCare fraud and abuse.

  • Legislation: HB 1012 by Shepard / SB 0914 by Johnson
  • Result: Considered but not passed
  • Summary Statement: As introduced, requires pharmacies contracting with TennCare to post in a conspicuous place seen by pharmacists and pharmacy technicians a printed notice regarding reporting TennCare fraud and abuse.
  • No action taken in 2015.

TENNCARE OVERSIGHT COMMITTEE

  • Legislation: HB 0982 by Hill M, McCormick / SB 1295 by Hensley
  • Result: Considered but not passed
  • Summary Statement: As introduced, reestablishes the legislative oversight committees on TennCare and on children’s services.
  • No action taken in 2015.

90 DAY OPIOID/BENZODIAZEPINE EXCEPTION

  • Legislation: HB 0723 by Pody, VanHuss / SB 0021 by Beavers
  • Result: Considered but not passed
  • Summary Statement: As introduced, creates an exception to the prohibition against prescriptions of opioids or benzodiazepines in quantities greater than a 30-day supply when certain conditions are met; if an exception applies, the prescription quantity may not be greater than a 90-day supply.
  • No action taken in 2015

HEALTHCARE IMPROVEMENT ACT

  • Legislation: HB 0861 by Harrison / SB 0521 by Hensley
  • Result: Considered but not passed
  • Citation: As introduced, enacts the “Tennessee Healthcare Improvement Act of 2015″ to establish physician-led patient care teams to oversee the practice of advanced practice registered nurses.
  • No action taken in 2015.

NURSING SCOPE OF PRACTICE

  • Legislation: HB 0456 by Favors, Goins / SB 0680 by Massey, Bowling
  • Result: Considered but not passed
  • Summary Statement: As introduced, changes the title of advance practice nurses to advanced practice registered nurses and changes references to their credentials from certificates to licenses; revises other provisions governing the practice of advanced practice nursing.
  • No action taken in 2015.

ABUSE-DETERRENT OPIOID ANALGESIC

  • Legislation: HB 0746 by Harrison, Lamberth, Lundberg, Weaver, Hill T / SB 0601 by Dickerson
  • Result: Considered but not passed
  • Summary Statement: As introduced, requires all health insurance coverage to provide coverage for abuse-deterrent opioid analgesic drugs at the same price as other opioid analgesic drugs.
  • No action taken in 2015.

This legislative summary above has been provided to TPA members for informational purposes only. The information in this summary is subjective, and members are encouraged to review the language in each law and make individual determinations based on their review. Members are encouraged to visit http://www.legislature.state.tn.us/ for a complete listing of all legislation.